HD
32
-6
DLTR
48
4
MSI
50
3
SO
77
4
GPC
31
2
TGNA
62
3
HP
32
4
CSX
41
4
NVDA
65
-13
KMB
37
7
VLO
36
4
PCAR
56
4
PPL
59
9
PDCO
46
5
PHM
68
4
UAL
47
6
PPG
68
6
EW
44
-2
GOOG
63
2
EXR
48
6
HD
32
-6
DLTR
48
4
MSI
50
3
SO
77
4
GPC
31
2
TGNA
62
3
HP
32
4
CSX
41
4
NVDA
65
-13
KMB
37
7
VLO
36
4
PCAR
56
4
PPL
59
9
PDCO
46
5
PHM
68
4
UAL
47
6
PPG
68
6
EW
44
-2
GOOG
63
2
EXR
48
6
Financhill
Back

Viking Therapeutics Stock Predictions

Buy
53

VKTX
Viking Therapeutics

Last Price:
62.28
Seasonality Move:
10.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Viking Therapeutics Stock Forecast

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 133.2% based on the past 9 years of stock performance.
  • Viking Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is Viking Therapeutics Stock Undervalued?
    The current Viking Therapeutics [VKTX] share price is $62.30. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Viking Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 133.2% based on the past 9 years of stock performance.

Viking Therapeutics Stock Rating

Buy
53
Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics overpriced?

  • Viking Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Viking Therapeutics Stock Price History

Is VKTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com

52-Week Data

52-Week High:
99.41
52-Week Low:
8.28

Prediction Charts

Market Cap:
6.87B
Price in USD:
62.30
Volume:
1.79M
Beta:
1.50

Technical Analysis

SMA50:
71.49
SMA100:
57.41
SMA200:
35.49
52-Wk Change:
183.7%

Stock Predictions

  • Is Viking Therapeutics stock public?
    Yes, Viking Therapeutics is a publicly traded company.
  • What is the Viking Therapeutics stock quote today?
    The Viking Therapeutics stock price is 62.30 USD today.
  • How to buy Viking Therapeutics stock online?
    You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-13 74.39 72.35 74.95 70.43
May-14 72.88 72.50 74.21 71.55
May-15 73.97 78.01 79.88 72.69
May-16 76.26 69.06 76.89 68.40
May-17 69.99 67.00 71.09 66.68
May-20 66.85 67.52 68.53 66.18
May-21 67.42 64.23 67.60 63.66
May-22 64.63 63.01 64.63 62.25
May-23 63.85 61.57 64.98 61.09
May-24 62.20 62.75 64.24 61.43
May-28 63.46 65.37 65.90 62.33
May-29 64.00 63.77 64.79 63.03
May-30 63.89 61.78 64.88 60.68
May-31 62.22 62.30 63.50 61.51

Viking Therapeutics Earnings

Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Viking Therapeutics Forecast Revenue Growth

Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.